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In this issue of Developmental Cell, Kernohan et al. link the chromatin regulatory proteins ATRX, MeCP2,
CTCF, and cohesin with silencing of H19 and other imprinted genes during critical stages of postnatal brain
development, perhaps suggesting a common etiology for several human diseases that exhibit defects in
brain development and function.Chromatin architecture andgenomeorga-
nization play essential roles in establishing
the gene expression patterns that are crit-
ical for normal development and function.
A number of human disorders have been
identified whose primary genetic defect
is in loci whose gene products regulate
chromatin and chromosome architecture.
Examples includeRett syndrome,which is
associated with loss of function of the
methylated-DNA binding protein MeCP2;
Cornelia de Lange syndrome, which is
associated with mutations in the cohe-
sin-related factors SMC1A, SMC3, and
NIPBL; and Alpha-Thalassemia mental
Retardation, X-linked (ATR-X), which is
associated with mutations in ATRX, an
ATP-dependent chromatin remodeling
protein. All threeof thesediseasespresent
broad and partially overlapping pheno-
types that include deficits in brain devel-
opment and function. While the primary
regulatory defect for each of these
syndromes has been determined, the
challenge still exists to identify the down-
stream targets of these genes with the
goal of eventually developing appropriate
therapies. In this issue of Developmental
Cell, Kernohan et al. (2010) analyze the
roles of ATRX, cohesin, and MeCP2 at
the imprinted H19 gene and demonstrate
that these factors interact together with
the transcription factor/insulator protein
CTCF to regulate expression of an entire
network of imprinted genes. This leads to
the intriguing hypothesis that changes in
expression of imprinted genes may
contribute to the brain defects associated
with these diseases.
The Igf2/H19 locus is a typical imprinted
gene cluster (Wan and Bartolomei, 2008).
It includes paternally expressed genes,Insulin2 and Insulin-like growth factor 2
(Igf2), and one maternally expressed
gene, H19. The maternal and paternal
chromosomes differ not only in gene
activity but also in chromosome architec-
ture. They display distinct patterns of
DNA methylation, histone modification,
and DNA loop formation. All of the differ-
ences across the >100 kb locus depend
entirely upon a 2.4 kb element, the H19
Imprinting Control Region (ICR) that
lies just adjacent to the H19 promoter
and about 100 kb upstream of Igf2 and
Insulin2. Deletion of the ICR renders
the two chromosomes indistinguishable,
while insertion of this element ectopically
will result in artificial imprinting of the tar-
geted locus. Maternally inherited ICR
DNA is not methylated and binds the
CTCF transcription factor in a cohesin-
dependent manner, resulting in expres-
sion of H19 in the embryo and early
neonatal stages. Moreover, CTCF-bound
maternal ICR interacts through DNA
loopingwith the Igf2 promoter region, pre-
venting Igf2 promoters from physically
interacting/looping with downstream en-
hancers. In contrast, paternal ICR DNA is
methylated and therefore cannot bind
CTCF. Since CTCF-dependent loops are
not formed between the ICR and the Igf2
gene on the paternal chromosome, the
Igf2 promoters are instead free to interact
with the downstream enhancers and acti-
vate paternal expression. In addition, the
methylated ICR induces chromatin
changes at the adjacent H19 promoter
that prevent its activation.
Besides these intrachromosomal inter-
actions, recent studies have demon-
strated CTCF-dependent interchromo-
somal interactions between the maternalDevelopmental Cell 18,H19 ICR and other loci, with a particular
enrichment for imprinted genes (Ling
et al., 2006; Sandhu et al., 2009; Zhao
et al., 2006). Thus there is quite a lot going
on at the H19 ICR, and Kernohan et al.
demonstrate that the element also repre-
sents a locus of integration, linking di-
verse disease loci.
Based on initial findings that H19 and
Igf2 were significantly upregulated in
ATRX/ mice, Kernohan et al. charac-
terize protein complexes at the H19 ICR.
They demonstrate that in addition to co-
hesin and CTCF, ATRX and MeCP2 also
bind specifically to the maternal (i.e., non-
methylated) ICR. Furthermore, cohesin
and CTCF binding are ATRX dependent.
The MeCP2 binding to the maternal ICR
is surprising, since it was always assumed
that this CpG methyl-binding protein in-
teracted specifically with the methylated
paternal ICR. Kernohan’s results thus
support newer hypotheses that MeCP2’s
primary role is in forming DNA loops that
stimulate gene activity and is not limited
to mediating DNA-methylation-induced
repression (LaSalle, 2007).
The increase in H19 expression in
ATRX-deficient mice is maternal in origin,
i.e., exhibits no loss of imprinting. This
implicates ATRX in postnatal repression
of H19 (and possibly Igf2). After birth, ex-
pression of these two genes is repressed
hundreds of fold. The biological necessity
for this repression is absolute, but the
underlying mechanisms have been elu-
sive until now. The authors do not deter-
mine the parental origin of the extra Igf2,
but their results predict that it is likely
maternal in origin.
Kernohan et al. also demonstrate inter-
actions of cohesin, MeCP2, and ATRXFebruary 16, 2010 ª2010 Elsevier Inc. 169
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case their analyses did not allow them to
determine whether these interactions
occur on the maternal or on the paternal
chromosome. The Dlk1/Glt2 locus is
somewhat analogous to the Igf2/H19
locus in gene organization and regulation
(Wan and Bartolomei, 2008). An ICR adja-
cent to the Gtl2 promoter regulates Gtl2
and the far upstream Dlk1. The results of
Kernohan et al. support the idea that inter-
actions of cohesin, MeCP2, and ATRX
proteins are of general importance and
not restricted to H19/Igf2. However,
several differences between the two loci
suggest that the nature of these interac-
tions may not be straightforward. At
Dlk1/Glt2, the proteins each bind to
distinct parts of the ICR and not to a single
region, like they do at the H19 locus.
Furthermore, MeCP2 binding to the ICR
is ATRX dependent at Glt2, but ATRX
independent at H19.
By several criteria, Igf2, H19, Dlk1, and
Glt2 are part of a network of at least 10 im-
printed genes (Varrault et al., 2006). These
genes all share developmental and tissue-
specific patterns of expression and re-
spond similarly to mutations at the Zac1
locus. Curiously this network shows
almost no overlap with imprinted genes
involved in interchromosomal interactions170 Developmental Cell 18, February 16, 201with the H19 ICR. Kernohan et al. provide
good evidence that ATRX is required for
the downregulation of expression of
each of these genes in late embryonic or
in postnatal development. The key ques-
tion remains whether this downregulation
is important in the ATR-X syndrome.
Evolutionary theory and the analysis of
many knockout mouse strains both
support the idea that the primary effect
of imprinting is on fetal and early neonatal
growth. However, some experiments
have suggested a role for imprinted genes
in brain development and function (Wilkin-
son et al., 2007). Chimeric animals gener-
ated by mixtures of wild-type and gyno-
genetic (maternal chromosomes only)
cells, or by mixtures of wild-type and an-
drogenetic (paternal chromosomes only)
cells, show divergent phenotypes with gy-
nogenetic and androgenetic cells each
contributing to distinct brain structures
(Keverne et al., 1996). These experiments
are hard to interpret on a molecular level.
Gynogenetic cells not only lack any
paternal-specific transcripts, but also
have 2-fold overexpression of all ma-
ternal-specific RNAs. Nonetheless the
results are intriguing. Mammalian cells
go to great effort to carefully regulate the
doses of imprinted genes. Whether mis-
expression of H19 or of any of the im-0 ª2010 Elsevier Inc.printed genes plays a clinically important
role in brain development and function is
an important and difficult question that
remains to be addressed.
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Transmembrane growth factor and integrin matrix receptors form multiprotein signaling complexes with
FAK, a cytoplasmic cell motility-associated kinase. In a recent issue of Molecular Cell, Long et al. now
show that a PAK-phosphorylated alternate-spliced isoform of the steroid receptor coactivator-3
(SRC-3D4) bridges EGFR and FAK, enhancing breast carcinoma cell migration and metastasis.Cell movement results from the coordina-
tion of actin cytoskeletal and cell adhe-
sion site formation-turnover alterations
generating shape and traction force
changes. Focal adhesion kinase (FAK) is
a cytoplasmic tyrosine kinase that coloc-
alizes with and is activated by integrinmatrix receptors at adhesion sites. For
a cell to process motility-promoting
stimuli correctly, there must be essential
proteins that function as ‘‘integrators’’ in
the coordination of signals regulating cell
shape, adhesion, and cell motility. FAK is
one such integrator linking transmem-brane integrin, growth factor, and G
protein-linked receptors to the cell motility
machinery (Mitra et al., 2005). FAK is
required for efficient epidermal growth
factor (EGF)-stimulated cell motility and
this connection is facilitated through FAK
FERM (band 4.1, ezrin, radixin, moesin
